Activity: Membership › Membership of board › Academic
About the journal Immunotherapy Advances is a fully Open Access peer-reviewed journal brought to you by the British Society for Immunology and edited by world leading immunologist Professor Tim Elliott, supported by a global editorial board of experts from academia and industry. Scope & mission Immunotherapy Advances publishes scientifically rigorous research relating to manipulations of the immune system for the benefit of human and animal health in all disease areas. The journal covers the translational pipeline for immunotherapy from discovery research and preclinical animal models through to clinical trials. Experimental medicine and first-in-human clinical studies are encouraged, and negative clinical trials are welcomed where they contribute to immune-mechanistic insight. We also recognise the growing importance of interdisciplinary working in this area and encourage studies that are at the interface with engineering, mathematics and computer science, chemistry and the physical sciences.